Sanofi Faces China Bribery Probe Over Whistleblower Claims
Sanofi SA on Monday confirmed that it had been accused by a whistleblower of paying kickbacks to Chinese doctors for prescriptions under the guise of "research grants," following reports that Chinese...To view the full article, register now.
Already a subscriber? Click here to view full article